Literature DB >> 35400009

Age-related Survival Outcomes for Pancreatic Cancer by Age.

Ali Abbaszadeh Kasbi1, Mohammed Ali Ashary1, Mizba Baksh1, Samuel Nussbaum1, Kristopher Attwood1, Emmanuel Gabriel1.   

Abstract

Background/Aim: Pancreatic cancer has a very poor prognosis, though outcomes based on age are not well characterized. The aim of current study was to analyze the survival of patients with pancreatic cancer based on age. Patients and
Methods: Using National Cancer Data Base (NCDB), we determined survival outcome based on age among patients with pancreatic cancer.
Results: A total of 423,482 patients between 2004 and 2017 were included in the study. Patients aged between 18 and 40-years-old had the worst 3-year survival rate among stage 1 disease. Conversely, patients over 65-years-old had the worst 3-year survival rate and presented with more advanced disease (clinical stages 3 and 4).
Conclusion: Older patients with more advanced disease had worse survival. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  NCDB; pancreatic cancer; prognostic factors; survival

Year:  2022        PMID: 35400009      PMCID: PMC8962847          DOI: 10.21873/cdp.10078

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  18 in total

Review 1.  Pancreatic cancer.

Authors:  Jonathan D Mizrahi; Rishi Surana; Juan W Valle; Rachna T Shroff
Journal:  Lancet       Date:  2020-06-27       Impact factor: 79.321

Review 2.  Molecular subtypes of pancreatic cancer.

Authors:  Eric A Collisson; Peter Bailey; David K Chang; Andrew V Biankin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-04       Impact factor: 46.802

3.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.

Authors:  Vinamrata Singal; Ashwani K Singal; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

4.  Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Jordan M Cloyd; Chengli Shen; Heena Santry; John Bridges; Mary Dillhoff; Aslam Ejaz; Timothy M Pawlik; Allan Tsung
Journal:  J Natl Compr Canc Netw       Date:  2020-05       Impact factor: 11.908

5.  Age-Based Trends of Gastric Adenocarcinoma in the United States.

Authors:  Denslow Trumbull; Riccardo Lemini; Enrique F Elli; Sanjay P Bagaria; Kristopher Attwood; Emmanuel Gabriel
Journal:  Am Surg       Date:  2020-08-31       Impact factor: 0.688

6.  Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.

Authors:  Melissa M Murphy; Jessica P Simons; Joshua S Hill; Theodore P McDade; Sing Chau Ng; Giles F Whalen; Shimul A Shah; Lynn H Harrison; Jennifer F Tseng
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

Review 7.  Modifiable and non-modifiable risk factors for pancreatic cancer: A review.

Authors:  Shallu Midha; Saurabh Chawla; Pramod Kumar Garg
Journal:  Cancer Lett       Date:  2016-07-25       Impact factor: 8.679

8.  Pancreatic cancer: why is it so hard to treat?

Authors:  Paul E Oberstein; Kenneth P Olive
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

9.  Gastric Cancer Disparities Among Asian American Subpopulations.

Authors:  Denslow Trumbull; Riccardo Lemini; Kristopher Attwood; Moshim Kukar; Emmanuel Gabriel
Journal:  Anticancer Res       Date:  2020-11       Impact factor: 2.480

10.  Age-related rates of colorectal cancer and the factors associated with overall survival.

Authors:  Emmanuel Gabriel; Kristopher Attwood; Eisar Al-Sukhni; Deborah Erwin; Patrick Boland; Steven Nurkin
Journal:  J Gastrointest Oncol       Date:  2018-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.